Harold A. Franch

Harold A. Franch

Auto-generated profile, based on publicly available information

Harold A. Franch

Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2006 in Circulation
Verified
Journal Article
Closed access
PDF file
ALAlice H. Lichtenstein
Alice H. Lichtenstein
LALawrence J. Appel
Lawrence J. Appel
MBMichael Brands
Michael Brands
MCMercedes Carnethon
Mercedes Carnethon
SDStephen Daniels
Stephen Daniels
JWJudith Wylie-Rosett
Judith Wylie-Rosett
Improving diet and lifestyle is a critical component of the American Heart Association’s strategy for cardiovascular disease risk reduction in the general population. This document presents recommendations designed to meet this objective. Specific goals are to consume an overall healthy diet; aim for a healthy body weight; aim for recommended levels of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides; aim for normal blood pressure; aim for a normal blood glucose level; be physically active; and avoid use of and exposure to tobacco products. The recommendations are to balance caloric intake and physical activity to achieve and maintain a healthy body weight; consume a diet rich in vegetables and fruits; choose whole-grain, high-fiber foods; consume fish, especially oily fish, at least twice a week; limit intake of saturated fat to <7% of energy, trans fat to <1% of energy, and cholesterol to <300 mg/day by choosing lean meats and vegetable alternatives, fat-free (skim) or low-fat (1% fat) dairy products and minimize intake of partially hydrogenated fats; minimize intake of beverages and foods with added sugars; choose and prepare foods with little or no salt; if you consume alcohol, do so in moderation; and when you eat food prepared outside of the home, follow these Diet and Lifestyle Recommendations. By adhering to these diet and lifestyle recommendations, Americans can substantially reduce their risk of developing cardiovascular disease, which remains the leading cause of morbidity and mortality in the United States.

1 February 2008 in Kidney International
Verified
Journal Article
Open access
PDF file
DFDenis Fouque
Denis Fouque
Kamyar Kalantar-ZadehKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
JKJ. Kopple
J. Kopple
NCN. Cano
N. Cano
PCP. Chauveau
P. Chauveau
CWC. Wanner
C. Wanner
The recent research findings concerning syndromes of muscle wasting, malnutrition, and inflammation in individuals with chronic kidney disease (CKD) or acute kidney injury (AKI) have led to a need for new terminology. To address this need, the International Society of Renal Nutrition and Metabolism (ISRNM) convened an expert panel to review and develop standard terminologies and definitions related to wasting, cachexia, malnutrition, and inflammation in CKD and AKI. The ISRNM expert panel recommends the term ‘protein–energy wasting’ for loss of body protein mass and fuel reserves. ‘Kidney disease wasting’ refers to the occurrence of protein–energy wasting in CKD or AKI regardless of the cause. Cachexia is a severe form of protein–energy wasting that occurs infrequently in kidney disease. Protein–energy wasting is diagnosed if three characteristics are present (low serum levels of albumin, transthyretin, or cholesterol), reduced body mass (low or reduced body or fat mass or weight loss with reduced intake of protein and energy), and reduced muscle mass (muscle wasting or sarcopenia, reduced mid-arm muscle circumference). The kidney disease wasting is divided into two main categories of CKD- and AKI-associated protein–energy wasting. Measures of chronic inflammation or other developing tests can be useful clues for the existence of protein–energy wasting but do not define protein–energy wasting. Clinical staging and potential treatment strategies for protein–energy wasting are to be developed in the future.

1 March 2013 in Journal of Renal Nutrition
Verified
Journal Article
Open access
PDF file
JCJuan Jesús Carrero
Juan Jesús Carrero
PSPeter Stenvinkel
Peter Stenvinkel
LCLilian Cuppari
Lilian Cuppari
TITalat Alp Ikizler
Talat Alp Ikizler
Kamyar Kalantar-ZadehKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
HFHarold A. Franch
Harold A. Franch
Protein-energy wasting (PEW), a term proposed by the International Society of Renal Nutrition and Metabolism (ISRNM), refers to the multiple nutritional and catabolic alterations that occur in chronic kidney disease (CKD) and associate with morbidity and mortality. To increase awareness, identify research needs, and provide the basis for future work to understand therapies and consequences of PEW, ISRNM provides this consensus statement of current knowledge on the etiology of PEW syndrome in CKD. Although insufficient food intake (true undernutrition) due to poor appetite and dietary restrictions contribute, other highly prevalent factors are required for the full syndrome to develop. These include uremia-induced alterations such as increased energy expenditure, persistent inflammation, acidosis, and multiple endocrine disorders that render a state of hypermetabolism leading to excess catabolism of muscle and fat. In addition, comorbid conditions associated with CKD, poor physical activity, frailty, and the dialysis procedure per se further contribute to PEW.

1 December 2013 in Kidney International
Verified
Journal Article
Closed access
PDF file
TITalat Alp Ikizler
Talat Alp Ikizler
NCNoel J. Cano
Noel J. Cano
HFHarold Franch
Harold Franch
DFDenis Fouque
Denis Fouque
JHJonathan Himmelfarb
Jonathan Himmelfarb
CWChristoph Wanner
Christoph Wanner

18 September 2012 in Circulation
Verified
Journal Article
Open access
PDF file
DMDariush Mozaffarian
Dariush Mozaffarian
AAAshkan Afshin
Ashkan Afshin
NBNeal L. Benowitz
Neal L. Benowitz
VBVera Bittner
Vera Bittner
SDStephen R. Daniels
Stephen R. Daniels
NZNeil A. Zakai
Neil A. Zakai
Background—: Poor lifestyle behaviors, including suboptimal diet, physical inactivity, and tobacco use, are leading causes of preventable diseases globally. Although even modest population shifts in risk substantially alter health outcomes, the optimal population-level approaches to improve lifestyle are not well established. Methods and Results—: For this American Heart Association scientific statement, the writing group systematically reviewed and graded the current scientific evidence for effective population approaches to improve dietary habits, increase physical activity, and reduce tobacco use. Strategies were considered in 6 broad domains: (1) Media and educational campaigns; (2) labeling and consumer information; (3) taxation, subsidies, and other economic incentives; (4) school and workplace approaches; (5) local environmental changes; and (6) direct restrictions and mandates. The writing group also reviewed the potential contributions of healthcare systems and surveillance systems to behavior change efforts. Several specific population interventions that achieved a Class I or IIa recommendation with grade A or B evidence were identified, providing a set of specific evidence-based strategies that deserve close attention and prioritization for wider implementation. Effective interventions included specific approaches in all 6 domains evaluated for improving diet, increasing activity, and reducing tobacco use. The writing group also identified several specific interventions in each of these domains for which current evidence was less robust, as well as other inconsistencies and evidence gaps, informing the need for further rigorous and interdisciplinary approaches to evaluate population programs and policies. Conclusions—: This systematic review identified and graded the evidence for a range of population-based strategies to promote lifestyle change. The findings provide a framework for policy makers, advocacy groups, researchers, clinicians, communities, and other stakeholders to understand and implement the most effective approaches. New strategic initiatives and partnerships are needed to translate this evidence into action.

1 October 2006 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
ALAlice H Lichtenstein
Alice H Lichtenstein
LALawrence J. Appel
Lawrence J. Appel
MBMichael Brands
Michael Brands
MCMercedes Carnethon
Mercedes Carnethon
SDStephen Daniels
Stephen Daniels
JWJudith Wylie-Rosett
Judith Wylie-Rosett